A novel gene therapy developed by researchers at the University of California San Diego School of Medicine has shown encouraging results in halting brain damage and preserving cognitive function in Alzheimer’s disease, a condition that affects millions worldwide. The study, recently published in the journal Signal Transduction and Targeted Therapy, presents a promising new strategy.
